Heartseed Inc.

Public

Heartseed Inc. is now publicly traded

The data on this page reflects Heartseed Inc.'s private-market history up to the point it went public, including its funding rounds, valuation, and investors.

Last Round

Series D

May 25, 2023

Total Funding Raised

$84.6M

Company Overview

Heartseed Inc. operates in Biotech and is based in Tokyo, Tokyo. It has raised $84.6M.

Heartseed Inc. is a biotechnology company that develops and commercializes iPS cell-derived cardiomyocyte replacement therapy for advanced heart failure.

Sector

Biotech

AI Layer

Non-AI

Heartseed Inc. Comparables

Compare Heartseed Inc. with similar companies based on industry and business-model similarity.

Heartseed Inc. comparables — related companies by embedding similarity
Company	Similarity	Market Cap
LizarBio Therapeutics	70%	Demo
Alder Therapeutics	66%	Demo
RenewalBio	63%	Demo

Book a demo to see all comparables

For institutional investors. Book with your work email.

Heartseed Inc. Funding Rounds

Historical fundraising activity

Data table
Round	Date	Amount Raised	Valuation	Investors	Sources
Series D	May 25, 2023	Demo	Demo	Demo	Demo
Series C	Jun 11, 2021	Demo	Demo	Demo	Demo
Series B	Nov 22, 2019	Demo	Demo	Demo	Demo
Series A	Jul 30, 2018	Demo	Demo	Demo	Demo

Book a demo to see all funding rounds

For institutional investors. Book with your work email.

Key People

Founding team and executive leadership

Kikuo Yasui

Chief Operating Officer

Executive Team

For institutional investors. Book with your work email.

Heartseed Inc. Investors

Notable investors and investment history

Heartseed Inc. investors
Investor	Rounds
Angel Bridge	Series A
Keio Innovation Initiative	Series D, Series C
Medical Incubator Japan	Series D, Series C
Nissay Capital	Series B, Series C
Astellas Venture Management	Series A, Series B
Sumitomo Mitsui Trust Investment	Series D, Series C
Sumitomo Mitsui Banking Corporation	Series B, Series C